Pharma: Page
-
PharmaVoice Team/PharmaVoice
The Marketers
New Media Mavens These tech-savvy marketers are energized by the possibilities present in the plethora of social media and other cutting-edge message-delivery tools. Alyson Connor • Driving Better Health Behaviors Curious. Passionate. Alyson Connor was a zookeeper. Alyson Connor can make the mos...
By PharmaVoice Team • July 26, 2011 -
PharmaVoice Team/PharmaVoice
The Clinical Specialists
Instinctive Innovators These experts in the clinical arena are evolving research and development practices, technologies, and development models to help bring new products to market faster, more cost-effectively, and with improved safety profiles. Mitchell Katz, Ph.D. • Leading by Example Suppor...
By PharmaVoice Team • July 26, 2011 -
Explore the Trendline➔
Getty Images
TrendlineTech for Clinical Trials
Companies that utilize these emerging technologies wisely are likely to find an edge in the increasingly competitive drug development arena.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
The Researchers & Scientists
Scientific Pathfinders As R&D becomes more focused and specialized, these research experts are leading the way by breaking new ground. Julian Adams, Ph.D., is leading the charge in the war against cancer. Dr. Adams is best known for the discovery and development of Velcade (bortezomib), a pro...
By PharmaVoice Team • July 26, 2011 -
PharmaVoice Team/PharmaVoice
Namaste India: Growth Across the Board
India’s importance in the pharmaceutical space is indisputable. With healthcare booming, a strong medical infrastructure, lower costs, and high levels of patient recruitment and retention, India presents enormous potential. The pharmaceutical business has been growing by 12% to 13% over the past ...
By Kim Ribbink • March 7, 2011 -
PharmaVoice Team/PharmaVoice
Emerging Market: China
Whether it is partnering, acquisitions, or the expansion of operations, China spells opportunity for the pharmaceutical industry. Increasingly, global pharmaceutical companies are either expanding their own operations within China or choosing to partner with China-based companies. According to IM...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
Digital Marketing: Dare to be Different
Research shows creativity is one of the most important components of a successful campaign, however, our experts say there are several other elements behind a campaign that need to be present to make the best of what digital media have to offer. Among them are matching the audience with the most ...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Timothy HAYES Bayer Adds Global Business Development Oversight Timothy Hayes, currently senior VP and region head for Bayer HealthCare’s Consumer Care division in North America, has assumed the additional responsibility of leading the business unit’s global business developmen...
By PharmaVoice Team • Sept. 28, 2010 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Tibco Unveils Solution for Accelerating Drug Development C3i Offers Subscription-Based Data Management Hosting Medidata Adds Supply Management, Source Document Verification Solutions Chiltern Solution Consolidates...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
The CREATIVES
Let the Force be Creative These rock stars of healthcare advertising are infusing their creative passion and energy into healthcare communications across all media. There is no off switch for Jamie Cobb, Executive Creative Director at MicroMass Communications; he is always on, always thinking, a...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The MARKETERS
The next big idea lies in pushing beyond comfort zones, and Dan Bobear fearlessly tackles issues head-on and challenges all who work with him to feed their minds to achieve marketing excellence. In leading his team at Palio, he breaks down the unpredictable and channels his colleagues’ energy a...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The Researchers & SCIENTISTS
A Diagnosis of Type 1 diabetes at the age of 6 and an early passion for science and research have propelled Randy Anderson, Ph.D., to become a force in the fight against the disease. Dr. Anderson has been making inroads into unraveling the mysteries of the disease since his senior-year zoology c...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Generics coming home to roost… By now, everyone in the pharmaceutical industry realizes that billions and billions of sales of branded products are going away, and the impact of this is going to be huge. According to IMS Health, the 5% to 8% compound annual growth rate during the next five years ...
By Taren Grom • May 24, 2010 -
PharmaVoice Team/PharmaVoice
The Package Deal
PharmaVOICE Container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, or device, or any likeness thereof, of a drug manufacturer, pro cessor, packer, or distributor other than the per son or persons who in fact manufactured, pro ce...
By Elizabeth Pena • Jan. 18, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Jack GOLDSTEIN Chiron Names Blood Testing Division President Chiron Corp. has named Jack Goldstein, Ph.D., president of Chi ron’s blood testing division. Dr. Goldstein is responsible for the commercial operations of Chiron’s blood testing business, based in Emeryville, Calif. He a...
By PharmaVoice Team • Jan. 13, 2010 -
PharmaVoice Team/PharmaVoice
Raise Your Voice: Letters
Missed opportunity I applaud the fact that PharmaVOICE has highlighted the importance of the new PhRMA Voluntary Marketing Code, but I would be remiss if I didn’t ask: “Where in this article is the discussion about the benefit of the new code to the patient?” In reading through this 11 page artic...
By PharmaVoice Team • Jan. 13, 2010 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski CONTRIBUTING EDITORS Virginia Kirk Denise Myshko Elisabeth Pena Kim Ribbink Alex Robinson Lynda Sears Copyright 2002 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Two, Numb...
By Taren Grom • Jan. 13, 2010 -
PharmaVoice Team/PharmaVoice
The IRS vs. Independent Contractors
Many pharmaceutical companies are now using independent contractors in increasing numbers; in many cases, these contractors are former employees. What started off as a trickle a few years ago has become a torrent. Quite often, former employees — whether they left voluntarily or not — end up back ...
By Andrew E. Schultz • Jan. 11, 2010 -
PharmaVoice Team/PharmaVoice
The Value of Innovation
BY ALEX ROBINSON Let’s stop complaining about spending on prescription drugs,” Alan Holmer, president of the Phar maceutical Research and Manufacturers of Ameri ca (PhRMA) told an audience in April. “In fact, let’s hope that prescription drug spending goes up — not down.” Critics are quick to poi...
By Alex Robinson • Jan. 11, 2010 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEB BASED APPLICATIONS, SITES, AND TECHNOLOGIES MDchoice.com Inc. has unveiled a new marketing platform that allows hospitals, clinics, and physician groups to offer their own private label online healthcare information services. The platform offers health information ranging f...
By PharmaVoice Team • Jan. 11, 2010 -
PharmaVoice Team/PharmaVoice
Pharmaceutical Manufacturing Under Scrutiny
Across the board — from labeling and marketing, to clinical trials, to manufacturing processes — regulators are becoming more active in safeguarding the public and ensuring the safety of pharmaceuticals. Even before the news broke regarding Genzyme Corp.’s recent virus and contamination problems ...
By PharmaVoice Team • Dec. 28, 2009 -
PharmaVoice Team/PharmaVoice
Felix Theeuwes — Durect Results
Results With more than 30 years experience in developing innovative drugdelivery technologies, Dr.Felix Theeuwes as chairman and chief scientific officer of Durect, is directing the startup company with the goal of commercializing pharmaceutical systems that . BY KIM RIBBINK Photos: Scott Lewis C...
By PharmaVoice Team • Nov. 4, 2009 -
PharmaVoice Team/PharmaVoice
Pharmacy Direct
In an effort to make it EASIER FOR PATIENTS to fill their prescriptions, some doctors’practices are bringing in VENDING MACHINE STYLE dispensers. BY JEAN LAWRENCE When patients leave Abbott Northwestern hospital in Minneapolis, they can now head straight home rather than to the drugstore. They al...
By Jean Lawrence • Nov. 4, 2009 -
PharmaVoice Team/PharmaVoice
Animal Farm — The Promise of Xenotransplantation
Animal Farm BY DENISE MYSHKO NO ONE WOULD DISPUTE THAT THERE IS A SHORTAGE OF HEARTS, KIDNEYS, OR LIVERS FOR THOSE WHO REQUIRE A NEW ONE. Last year in the United States alone, 6,000 people died while awaiting an organ transplant. Campaigns to increase organ donation have been somewhat successful ...
By PharmaVoice Team • Nov. 4, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Andrew R.J. BONFIELD Bristol Myers Squibb Appoints New Senior VP and Chief Financial Officer Andrew R.J. Bonfield joins Bristol Myers Squibb as senior VP and chief financial officer. Mr. Bonfield, 39, served most recently as executive director of finance at BGGroup Plc., a multibillio...
By PharmaVoice Team • Nov. 3, 2009 -
PharmaVoice Team/PharmaVoice
Pharma Outlet
There is a movement afoot to reform the system enacted to address patent disputes between pioneer drug developers and their generic drug competitors. When this system, referred to as the HatchWaxman Act, was passed in 1984, it was intended to balance the competing interests of pioneer pharmaceuti...
By Barbara Carter • Nov. 2, 2009
Previous
